{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/13983"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/13983","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"EVALUATION OF NEW PROBES AND APPROACHES FOR CORRELATING OPTICAL AND NUCLEAR IMAGING: APPLICATIONS IN CANCER DETECTION AND TREATMENT","abstract":"<p>The photophysical and biological properties of a series of novel molecules that can be used for dual-purpose molecular imaging (optical and nuclear) and therapy of cancer were evaluated. Specifically isostructural [2+1] Re/Tc complexes, a porphyrin conjugate and an antibody-recruiting small molecule construct capable of targeting prostate specific membrane antigen (PSMA) were assessed.</p> <p>The isostructural [2+1] metal complexes were synthesized to act as an optical probe when prepared using rhenium and a nuclear probe for SPECT when the core metal is <sup>99m</sup>Tc. The rhenium analogues were incubated with MCF-7 cells and confocal imaging was used to visualize the uptake of a rhenium bipyridine cyclohexyl nicotinate derivative. Uptake of the <sup>99m</sup>Tc complexes in MCF-7 cells were also measured and showed approximately 7% uptake for the pyridine methanol derivative and 5% for the cyclohexyl nicotinate derivative at 120 min. These results demonstrated the utility of the [2+1] isostructural compounds to create dual purpose optical/nuclear imaging agents.</p> <p>As a complementary approach to the [2+1] complexes, a series of targeted porphyrin derivatives were prepared and screened in vitro. A set of PSMA targeted chlorin e6 (Ce6) derivatives which act as isostructural molecular imaging probes and targeted photosensitizers for photodynamic therapy (PDT) were evaluated. Ce6 was linked to a potent glutamate-urea-lysine based inhibitor of prostate specific membrane antigen (PSMA), which is a transmembrane protein overexpressed in malignant prostate cancer. Studies in PSMA positive LNCaP cells showed greater uptake of the agents compared to cells with minimal PSMA expression.</p> <p>Building on the chlorin PSMA studies, a set of antibody-recruiting small molecules that target prostate cancer, and also act as a SPECT imaging agent (when radiolabeled with <sup>123</sup>I) or a radiotherapeutic (when labelled with <sup>131</sup>I) were developed. These small molecules consist of a PSMA-inhibitor on one end and 2,4-dinitrophenyl (DNP) group on the other which recruits anti-DNP antibodies. A plate reader assay was developed using a PSMA-positive cell line and fluorescently labeled anti-DNP to observe binding and recruitment of antibodies through fluorescence. An iodine-containing derivative with a PEG<sub>8</sub> chain between the PSMA inhibitor and DNP was found to be potent (IC<sub>50</sub> = 14 nM) and is therefore an attractive candidate for combined radio- and antibody recruiting therapy.</p>","abstract_html":"&lt;p&gt;The photophysical and biological properties of a series of novel molecules that can be used for dual-purpose molecular imaging (optical and nuclear) and therapy of cancer were evaluated. Specifically isostructural [2+1] Re/Tc complexes, a porphyrin conjugate and an antibody-recruiting small molecule construct capable of targeting prostate specific membrane antigen (PSMA) were assessed.&lt;/p&gt; &lt;p&gt;The isostructural [2+1] metal complexes were synthesized to act as an optical probe when prepared using rhenium and a nuclear probe for SPECT when the core metal is &lt;sup&gt;99m&lt;/sup&gt;Tc. The rhenium analogues were incubated with MCF-7 cells and confocal imaging was used to visualize the uptake of a rhenium bipyridine cyclohexyl nicotinate derivative. Uptake of the &lt;sup&gt;99m&lt;/sup&gt;Tc complexes in MCF-7 cells were also measured and showed approximately 7% uptake for the pyridine methanol derivative and 5% for the cyclohexyl nicotinate derivative at 120 min. These results demonstrated the utility of the [2+1] isostructural compounds to create dual purpose optical/nuclear imaging agents.&lt;/p&gt; &lt;p&gt;As a complementary approach to the [2+1] complexes, a series of targeted porphyrin derivatives were prepared and screened in vitro. A set of PSMA targeted chlorin e6 (Ce6) derivatives which act as isostructural molecular imaging probes and targeted photosensitizers for photodynamic therapy (PDT) were evaluated. Ce6 was linked to a potent glutamate-urea-lysine based inhibitor of prostate specific membrane antigen (PSMA), which is a transmembrane protein overexpressed in malignant prostate cancer. Studies in PSMA positive LNCaP cells showed greater uptake of the agents compared to cells with minimal PSMA expression.&lt;/p&gt; &lt;p&gt;Building on the chlorin PSMA studies, a set of antibody-recruiting small molecules that target prostate cancer, and also act as a SPECT imaging agent (when radiolabeled with &lt;sup&gt;123&lt;/sup&gt;I) or a radiotherapeutic (when labelled with &lt;sup&gt;131&lt;/sup&gt;I) were developed. These small molecules consist of a PSMA-inhibitor on one end and 2,4-dinitrophenyl (DNP) group on the other which recruits anti-DNP antibodies. A plate reader assay was developed using a PSMA-positive cell line and fluorescently labeled anti-DNP to observe binding and recruitment of antibodies through fluorescence. An iodine-containing derivative with a PEG&lt;sub&gt;8&lt;/sub&gt; chain between the PSMA inhibitor and DNP was found to be potent (IC&lt;sub&gt;50&lt;/sub&gt; = 14 nM) and is therefore an attractive candidate for combined radio- and antibody recruiting therapy.&lt;/p&gt;","abstract_has_math":false,"creators":["Banevicius, Laura"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Medical Physics","school":null,"contributors":[],"advisors":["Valliant, John F."],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-04","date_published":"2014-04","updated_at":"2026-11-18T19:38:36Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/21514"],"render_values":[{"text":"https://doi.org/10.71548/21514","href":"https://doi.org/10.71548/21514","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/8817","9758","4946738"],"render_values":[{"text":"opendissertations/8817","href":null,"code":true},{"text":"9758","href":null,"code":true},{"text":"4946738","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/13983","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/13983","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F13983","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Valliant, John F."]},{"key":"dc:contributor.department","label":"Department","values":["Medical Physics"]},{"key":"dc:creator","label":"Author","values":["Banevicius, Laura"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T17:05:49Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T17:05:49Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2013-12-29"]},{"key":"dc:date.issued","label":"Date","values":["2014-04"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/8817","9758","4946738"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/13983","https://doi.org/10.71548/21514"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The photophysical and biological properties of a series of novel molecules that can be used for dual-purpose molecular imaging (optical and nuclear) and therapy of cancer were evaluated. Specifically isostructural [2+1] Re/Tc complexes, a porphyrin conjugate and an antibody-recruiting small molecule construct capable of targeting prostate specific membrane antigen (PSMA) were assessed.</p> <p>The isostructural [2+1] metal complexes were synthesized to act as an optical probe when prepared using rhenium and a nuclear probe for SPECT when the core metal is <sup>99m</sup>Tc. The rhenium analogues were incubated with MCF-7 cells and confocal imaging was used to visualize the uptake of a rhenium bipyridine cyclohexyl nicotinate derivative. Uptake of the <sup>99m</sup>Tc complexes in MCF-7 cells were also measured and showed approximately 7% uptake for the pyridine methanol derivative and 5% for the cyclohexyl nicotinate derivative at 120 min. These results demonstrated the utility of the [2+1] isostructural compounds to create dual purpose optical/nuclear imaging agents.</p> <p>As a complementary approach to the [2+1] complexes, a series of targeted porphyrin derivatives were prepared and screened in vitro. A set of PSMA targeted chlorin e6 (Ce6) derivatives which act as isostructural molecular imaging probes and targeted photosensitizers for photodynamic therapy (PDT) were evaluated. Ce6 was linked to a potent glutamate-urea-lysine based inhibitor of prostate specific membrane antigen (PSMA), which is a transmembrane protein overexpressed in malignant prostate cancer. Studies in PSMA positive LNCaP cells showed greater uptake of the agents compared to cells with minimal PSMA expression.</p> <p>Building on the chlorin PSMA studies, a set of antibody-recruiting small molecules that target prostate cancer, and also act as a SPECT imaging agent (when radiolabeled with <sup>123</sup>I) or a radiotherapeutic (when labelled with <sup>131</sup>I) were developed. These small molecules consist of a PSMA-inhibitor on one end and 2,4-dinitrophenyl (DNP) group on the other which recruits anti-DNP antibodies. A plate reader assay was developed using a PSMA-positive cell line and fluorescently labeled anti-DNP to observe binding and recruitment of antibodies through fluorescence. An iodine-containing derivative with a PEG<sub>8</sub> chain between the PSMA inhibitor and DNP was found to be potent (IC<sub>50</sub> = 14 nM) and is therefore an attractive candidate for combined radio- and antibody recruiting therapy.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["EVALUATION OF NEW PROBES AND APPROACHES FOR CORRELATING OPTICAL AND NUCLEAR IMAGING: APPLICATIONS IN CANCER DETECTION AND TREATMENT"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Valliant, John F."],"dc:contributor.department":["Medical Physics"],"dc:creator":["Banevicius, Laura"],"dc:date.accessioned":["2014-06-18T17:05:49Z"],"dc:date.available":["2014-06-18T17:05:49Z"],"dc:date.created":["2013-12-29"],"dc:date.issued":["2014-04"],"dc:description.abstract":["<p>The photophysical and biological properties of a series of novel molecules that can be used for dual-purpose molecular imaging (optical and nuclear) and therapy of cancer were evaluated. Specifically isostructural [2+1] Re/Tc complexes, a porphyrin conjugate and an antibody-recruiting small molecule construct capable of targeting prostate specific membrane antigen (PSMA) were assessed.</p> <p>The isostructural [2+1] metal complexes were synthesized to act as an optical probe when prepared using rhenium and a nuclear probe for SPECT when the core metal is <sup>99m</sup>Tc. The rhenium analogues were incubated with MCF-7 cells and confocal imaging was used to visualize the uptake of a rhenium bipyridine cyclohexyl nicotinate derivative. Uptake of the <sup>99m</sup>Tc complexes in MCF-7 cells were also measured and showed approximately 7% uptake for the pyridine methanol derivative and 5% for the cyclohexyl nicotinate derivative at 120 min. These results demonstrated the utility of the [2+1] isostructural compounds to create dual purpose optical/nuclear imaging agents.</p> <p>As a complementary approach to the [2+1] complexes, a series of targeted porphyrin derivatives were prepared and screened in vitro. A set of PSMA targeted chlorin e6 (Ce6) derivatives which act as isostructural molecular imaging probes and targeted photosensitizers for photodynamic therapy (PDT) were evaluated. Ce6 was linked to a potent glutamate-urea-lysine based inhibitor of prostate specific membrane antigen (PSMA), which is a transmembrane protein overexpressed in malignant prostate cancer. Studies in PSMA positive LNCaP cells showed greater uptake of the agents compared to cells with minimal PSMA expression.</p> <p>Building on the chlorin PSMA studies, a set of antibody-recruiting small molecules that target prostate cancer, and also act as a SPECT imaging agent (when radiolabeled with <sup>123</sup>I) or a radiotherapeutic (when labelled with <sup>131</sup>I) were developed. These small molecules consist of a PSMA-inhibitor on one end and 2,4-dinitrophenyl (DNP) group on the other which recruits anti-DNP antibodies. A plate reader assay was developed using a PSMA-positive cell line and fluorescently labeled anti-DNP to observe binding and recruitment of antibodies through fluorescence. An iodine-containing derivative with a PEG<sub>8</sub> chain between the PSMA inhibitor and DNP was found to be potent (IC<sub>50</sub> = 14 nM) and is therefore an attractive candidate for combined radio- and antibody recruiting therapy.</p>"],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.other":["opendissertations/8817","9758","4946738"],"dc:identifier.uri":["http://hdl.handle.net/11375/13983","https://doi.org/10.71548/21514"],"dc:title":["EVALUATION OF NEW PROBES AND APPROACHES FOR CORRELATING OPTICAL AND NUCLEAR IMAGING: APPLICATIONS IN CANCER DETECTION AND TREATMENT"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:38:36Z"}